## NUE: Nucor Corporation - XLB: Basic Materials

### Executive Summary

VALUE thesis: PEG 0.75 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($152.29)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 1, Bearish: 2)

**1. Nucor sees lower Q4 earnings sequentially across all segments**
- Source: Steel Market Update | 20251217T175625 | Bearish | Relevance: 100%
- Nucor anticipates lower sequential earnings in Q4 2025 across all three operating segments due to seasonal effects and fewer shipping days, despite expecting higher earnings compared to Q4 2024. The steelmaker projects earnings per diluted share in the range of $1.65 to $1.75. Looking to 2026, Nucor is encouraged by materially higher backlogs driven by momentum in construction market segments like energy, infrastructure, data centers, and manufacturing.

**2. Nucor Faces Seasonal Headwinds In Q4, Yet Order Backlogs Signal 2026 Recovery**
- Source: Benzinga | 20251217T150809 | Neutral | Relevance: 100%
- Nucor (NYSE: NUE) shares are trading lower after the company issued fourth-quarter EPS guidance below analyst estimates, projecting $1.65â€“$1.75 compared to the $2.18 consensus. The company cited seasonal pressures and fewer shipping days for the expected decline across all three operating segments, but noted improving order backlogs heading into 2026. Nucor expects gradual improvements in business conditions for 2026, supported by favorable monetary, tax, and trade policies.

**3. Nucor expects Q4 earnings to decline amid seasonal effects**
- Source: Investing.com | 20251217T130840 | Somewhat-Bearish | Relevance: 100%
- Nucor Corporation anticipates a decline in its fourth-quarter 2025 earnings, projecting $1.65 to $1.75 per diluted share, down from $2.63 in Q3, attributing this to seasonal factors and fewer shipping days. Despite the expected Q4 dip across all operating segments, the company maintains an optimistic outlook for 2026, citing significantly higher backlogs. Nucor has also been active in share repurchases and recently increased its quarterly dividend, while leadership changes are expected in early 2026.

**4. TradeWell Securities LLC. Purchases 13,697 Shares of Nucor Corporation $NUE**
- Source: MarketBeat | 20251215T132732 | Bullish | Relevance: 100%
- TradeWell Securities LLC significantly increased its stake in Nucor Corporation (NYSE: NUE) by 219.5% in Q2, acquiring an additional 13,697 shares, bringing their total to 19,936 shares valued at $2.583 million. Other major institutional investors like Berkshire Hathaway and Norges Bank also established new positions, raising Nucor's institutional ownership to 76.48%. Despite insider selling activity, Nucor recently increased its quarterly dividend to $0.56, and analysts maintain a "Moderate Buy" rating with an average price target of $171.70.

**5. Nucor, Steel Dynamics Warn of Profit Shortfalls**
- Source: The Wall Street Journal | 20251217T143003 | Bearish | Relevance: 98%
- Steelmakers Nucor and Steel Dynamics have issued warnings that their fourth-quarter earnings will fall significantly short of Wall Street's expectations. Nucor anticipates earnings of $1.65 to $1.75 per share, below the $2.16 analyst forecast, while Steel Dynamics expects $1.65 to $1.69 per share, missing the $2.25 estimate. Both companies attribute the decline to seasonal effects and fewer shipping days.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Wells Fargo | $178 | $167 | +7% |
| 2025-12-10 | Jefferies | $190 | $170 | +12% |
| 2025-12-05 | JP Morgan | $200 | $175 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Wells Fargo | main | Overweight |
| 2025-12-10 | Jefferies | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($2.29M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-3.1%)
- State Farm Mutual Au: 10.6% (-0.7%)
- Blackrock Inc.: 8.1% (-3.6%)
- State Street Corpora: 5.3% (-2.7%)
- Berkshire Hathaway, : 2.8% (-3.1%)

### Key Risks

1. High beta (1.86) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +11%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.75 indicates undervaluation relative to growth. Forward P/E 13.8x attractive for 45% earnings growth. Balance sheet: strong liquidity (2.8x). Analyst sentiment positive (3 raises, avg +11%). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $36.8B |
| Beta | 1.86 |
| 52W Range | $97.59 - $168.07 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.75 |
| Forward P/E | 13.8 |
| Current P/E | 20.0 |
| YoY Growth | 45.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.4% to 3.0% (-1.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.0pp (needs >4.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.00% (CS: 57) | Neutral |
| RSI_14 | 57.1 | Neutral |
| MACD Histogram | -0.41 | Bearish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 1.076x | Above |
| vs SMA200 | 1.195x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $160.69
- **Stop Loss:** $152.29 (5.2% risk)
- **Target:** $177.49 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 128
- **Position Value:** $20,568.32
- **Portfolio %:** 20.57%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-01-26 (Est: $2.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.16 | $2.63 | +22.0% |
| 2025Q2 | $2.61 | $2.60 | -0.6% |
| 2025Q1 | $0.61 | $0.67 | +9.8% |
| 2024Q4 | $0.64 | $1.22 | +90.6% |

---
*RULE-based L3 | 2026-01-07 01:41 | MRS_20*